Charcot Marie Tooth Disease Flashcards
CMT 2 categories
Neuropathy is primary disorder
Neuropathy is part of a larger multi system disorder
CMT
Initially involves peroneal nerve and eventually affects muscles in foot and lower leg
Later progresses on to forearm and hands
CMT etiology
Autosomal dominant
Chromosomal deficits create duplication, deletion, or point mutations in code for proteins invovled in myelination
Two main subtypes of heterogenous polyneuropathy CMT
CMT1 (most common autosomal dominant pattern)
CMT2
CMT 1A
Primary 70% cases
Segmental demyelination of peroneal nerve
Ave NCV 15-20 m/s
(Normal ~40m/s)
CMT1B
5-10% of type 1
NCV <20
CMT1C
Dejerine stoats disease
Severe demyelination which can be detected by measuring NCV (266-42)
Autosminal dominant usually in infancy
CMT1D
NCV 15-20m/s
CMT1 foot structure
Pes cavus
CMT patho
Mutations in proteins responsible for Schwann cell myelination —> extensive demyelination and hypertrophic Schwann cell (onion bulb)—> enlarged peripheral nerves
CMT2
Less common,
20-40% CMT pts
Autosomal dominant w/ main affect on axon
NCV slightly below normal generally above 38
CMT2 associated w/
Mutation in myelin protein zero
Genetic mutations that disrupt neurofimalment assembly—> affect axon transport
Loss of anterior horn cells in lumboscarcal seg of SC and cell bodies in dorsal root ganglion—> axonal degeneration
CMT2 onset
B/n 2nd and 7th decade
Less involvement of small muscle of hands than CMT1
CMT diagnostic
History Hereditary Clinical presentations EMG and NCV Nerve biopsy
Distinguish b/n CMT1 and CMT2
Clinically impossible
CMT degrees of genetic dominance
Graded presentation
Linked (CMT2), men have signs of both demyelination and axonal degneration
CMT1 onset and progression
Slow and childhood
CMT s/s include
Distally symmetric muscle weakness, diminished DTR
Feet have pes cavus and hammer toes
High stepage gait secondary to DF and Evertor weakness
As CMT progresses
Weakness and wasting of intrinsic muscles of hands and eventually forearms
CMT1 presents
Demyelinates the peripheral nerve resulting in proprioceptive loss in feet and ankles and diminsihed cutaneous sensation
CMT 2 presents
W/ minimal sensory loss
Sensory symptoms can also include tingling and burning in feet and legs
CMT tx
No specific tx to alter course of disease
Tx is symptomatic to ensure fx maintained
Stretching and positioning is critical to maintain muscle length and joint mobility
PT intervention
Focused on endurance and strength training
Home based PRE, cycling, strength endurance
PT outcomes
Improved ADLS Gait speed Knee torque Subjective pain and fatigue VO2 max
CMT most promising tx
Pharmacology targeting genetic mutations
Anti cancer drug should be avoided and can cause exacerbation
CMT prognosis
Slowly progressive-manage impairments as they arise
IF CMT not managed
Contracture Progressive gait abnormalities Falls and secondary injuries Pressure sores Functional decline